This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Forum
March 22-25, 2026
The Westin Copley PlaceBoston, MA

Matthew D'Uva
CEO at American Association for the Study of Liver Diseases (AASLD) and the AASLD Foundation
Speaker

Profile

Matthew R. D’Uva, FASAE, CAE is Chief Executive Officer of the American Association for the Study of Liver Diseases (AASLD) and AASLD Foundation, where he is driving a more connected, innovative future for liver health worldwide. Leading a global community of clinicians, researchers, and scientists, he advances strategies that accelerate scientific innovation and build the hepatology workforce of tomorrow.

Matthew holds degrees from Tufts University and the University of Maryland and is a Fellow of ASAE and a Certified Association Executive.

Agenda Sessions

  • Navigating Differences: EU vs US International Medical Conferences

    1:20pm